Analysis of primary tumour burden revealed no significant difference in spleen weight between the inhibitor‐treated groups and vehicle controls (Figure 7B,C), consistent with our earlier findings that DHHC9 knockdown does not affect primary tumour growth. The gene discussed is ZDHHC9; the disease is neoplasm.